[Skip to Content]
[Skip to Content Landing]
Citations 0
December 19, 2007

Treatment of ANCA-Associated Vasculitis

Author Affiliations

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2007;298(23):2739-2740. doi:10.1001/jama.298.23.2739-b

To the Editor: Dr Bosch and colleagues1 considered the treatment of ANCA-associated vasculitis, discussing the relationship of its pathophysiology to current immunotherapy. The authors point out that although ANCA may be important in orchestrating neutrophil-mediated damage to the vascular endothelium, ANCA production is a T-cell driven process and novel forms of immunotherapy target this population of lymphocytes.

First Page Preview View Large
First page PDF preview
First page PDF preview